SecBot SecBot
SECBOTREPLAY Home › Report › RYTM

RYTM · Director Lynn Tetrault filed a Form 144 to sell 37,000 shares via…

RHYTHM PHARMACEUTICALS, INC. · 144 filed Jun 22, 2026 at 16:49 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 22, 2026 at 16:49 ET

Director Lynn Tetrault filed a Form 144 to sell 37,000 shares via option exercise, valued at approximately $3.58 million, under a 10b5-1 plan adopted on 12/15/2025. The sale is small relative to the company's $6.6B market cap and represents routine insider diversification with no material read-through for the stock.

  • Director Lynn Tetrault intends to sell 37,000 shares of common stock.
  • Estimated proceeds of $3,581,230 (based on filing price).
  • Sale is pursuant to a 10b5-1 plan adopted on 12/15/2025.
  • Sale date is 06/22/2026, same day as filing.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access